Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haner Direskeneli

Showing results (1-10 of 327) with videos related to

Pageof 33
Sort By:
Presse Medicale (Paris, France : 1983)|August 28, 2017
Takayasu's arteritis: A new era is approachingHaner Direskeneli
International Journal of Cardiology|November 5, 2018
Pulmonary hypertension in Takayasu's arteritis: Should be monitored closelyHaner Direskeneli
Clinical and Experimental Rheumatology|April 5, 2017
Clinical assessment in Takayasu's arteritis: major challenges and controversiesHaner Direskeneli
Current Pharmaceutical Design|February 28, 2012
Excess cardiovascular risk in inflammatory rheumatic diseases: pathophysiology and targeted therapyAltan Onat, Haner Direskeneli
Clinical and Experimental Rheumatology|September 28, 2010
A possible decline in the incidence and severity of Behçet's disease: implications for an infectious etiology and oral healthHaner Direskeneli, Gonca Mumcu
Internal and Emergency Medicine|December 8, 2018
Triggering agents and microbiome as environmental factors on Behçet's syndromeGonca Mumcu, Haner Direskeneli
Rheumatology (Oxford, England)|January 25, 2014
Quantifying disease involvement in Takayasu's arteritisPaul Bacon, Haner Direskeneli
Clinical Immunology (Orlando, Fla.)|July 30, 2023
Behçet's Disease: From Bench To BedsideAmr H Sawalha, Haner Direskeneli
Diagnostics (Basel, Switzerland)|January 8, 2023
Update on the Diagnosis of Behçet's DiseaseFatma Alibaz-Oner, Haner Direskeneli
Clinical and Experimental Rheumatology|April 5, 2017
Reply to: Assessing the role of pentraxin-3 in Takayasu's arteritis. De Luca G. et alFatma Alibaz-Oner, Haner Direskeneli
Pageof 33

Showing results (1-10 of 327) with videos related to

Sort By:
Pageof 33
Presse Medicale (Paris, France : 1983)|August 28, 2017
Takayasu's arteritis: A new era is approachingHaner Direskeneli
International Journal of Cardiology|November 5, 2018
Pulmonary hypertension in Takayasu's arteritis: Should be monitored closelyHaner Direskeneli
Clinical and Experimental Rheumatology|April 5, 2017
Clinical assessment in Takayasu's arteritis: major challenges and controversiesHaner Direskeneli
Current Pharmaceutical Design|February 28, 2012
Excess cardiovascular risk in inflammatory rheumatic diseases: pathophysiology and targeted therapyAltan Onat, Haner Direskeneli
Clinical and Experimental Rheumatology|September 28, 2010
A possible decline in the incidence and severity of Behçet's disease: implications for an infectious etiology and oral healthHaner Direskeneli, Gonca Mumcu
Internal and Emergency Medicine|December 8, 2018
Triggering agents and microbiome as environmental factors on Behçet's syndromeGonca Mumcu, Haner Direskeneli
Rheumatology (Oxford, England)|January 25, 2014
Quantifying disease involvement in Takayasu's arteritisPaul Bacon, Haner Direskeneli
Clinical Immunology (Orlando, Fla.)|July 30, 2023
Behçet's Disease: From Bench To BedsideAmr H Sawalha, Haner Direskeneli
Diagnostics (Basel, Switzerland)|January 8, 2023
Update on the Diagnosis of Behçet's DiseaseFatma Alibaz-Oner, Haner Direskeneli
Clinical and Experimental Rheumatology|April 5, 2017
Reply to: Assessing the role of pentraxin-3 in Takayasu's arteritis. De Luca G. et alFatma Alibaz-Oner, Haner Direskeneli
Pageof 33